Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07465562) titled 'Galactol(R) Enzyme Supplement for Post-Prandial Abdominal Bloating in Irritable Bowel Syndrome' on March 6.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Liaquat University of Medical & Health Sciences

Condition: Irritable Bowel Syndrome Abdominal Bloating

Intervention: Dietary Supplement: Galactol(R)

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: March 16, 2026

Target Sample Size: 300

Countries of Recruitment: Italy

To know more, visit https://...